Global Pharmacovigilance: TFS Orchestrates a Post-Marketing PV System

Download our case study to:

Discover how an oncology sponsor preparing for their first product approval successfully transitioned from the clinical to the post-approval phase and how TFS navigated through the complex task of consolidating safety data scattered across multiple CRO databases, implementing a new safety database, and setting up a post-marketing Pharmacovigilance (PV) system.

Learn about the effective strategies employed to ensure streamlined reporting, rapid decision-making, and efficient project tracking. TFS’ innovative approach of establishing a partnership framework, integrating the quality management systems of both parties, will be particularly interesting for those grappling with similar challenges. Download this case study to observe a compelling example of TFS’s expertise and commitment in the face of complex transitional challenges.

Learn more about our related services and resources:

TFS Oncology & Hematology | TFS Strategic Resourcing Solutions

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Oncology Expertise

The Value of Cross-Functional Expertise in Complex Oncology Clinical TrialsArticle

The Value of Cross-Functional Expertise in Complex Oncology Clinical Trials

Experienced Oncology CROs with cross-functional expertise strengthen complex oncology clinical trials and accelerates clinical development.
Customisation, partnerships and AI the keys to the future of clinical trials
From Strategy to Patients: Adaptability and Innovation in Trial DesignArticle

From Strategy to Patients: Adaptability and Innovation in Trial Design

Explore how adaptability, innovation, and patient focus can help sponsors rethink trial execution, from smarter sourcing models to the role of AI in oncology.
Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to KnowArticle

Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to Know

Explore key takeaways from ASCO 2025, from ctDNA and AI to novel biologics and inclusive trials. Learn how to stay ahead in oncology research.